 |
|
|
|
| Selected Reading |
 AAP Committee on Infectious Diseases. Antiviral therapy and prophylaxis for influenza in children. Pediatrics 2007 Apr;119(4):852-60 [Abstract]
AAP Committee on Infectious Diseases. Prevention of influenza: recommendations for influenza immunization of children, 2006-2007. Pediatrics 2007 Apr;119(4):846-51 [Abstract]
AAP Committee on Infectious Diseases. Prevention of influenza: recommendations for influenza immunization of children, 2007-2008. (Policy Statement) Pediatrics 2008 Apr;121(4):e1016-31 [Full text]
AAP Committee on Infectious Diseases. Prevention of influenza: recommendations for influenza immunization of children, 2008-2009. (Policy Statement) Pediatrics 2008 (published online Oct 1) [Full text]
Aballea s, De Juanes JR, Barbieri M, et al. The cost effectiveness of influenza vaccination for adults aged 50 to 64 years: a model-based analysis for Spain. Vaccine 2007 Sep 28;25(39-40):6900-10 [Abstract]
Abed Y, Baz M, Boivin G. A novel neuraminidase deletion conferring resistance to oseltamivir in clinical influenza A/H3N2 virus. J Infect Dis 2008 (published online Dec 1) [Abstract]
Abed Y, Goyette N, Boivin G. Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations. Antimicrob Agents Chemother 2005 Feb;49(2):556-9 [Abstract]
Ablah E, Konda K, Tinius A, et al. Influenza vaccine coverage and presenteeism in Sedgwick County, Kansas. Am J Infect Control 2008 Oct;36(8):588-91 [Abstract]
Abramson JS, Neuzil KM, Tamblyn SE. Annual universal influenza vaccination: ready or not? Clin Infect Dis 2006 Jan 1;42(1):132-5 [Full text]
Alarcon JB, Hartley AW, Harvey NG, et al. Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines. Clin Vaccine Immunol 2007 Apr;14(4):375-81 [Abstract]
Albright FS, Orlando P, Pavia AT, et al. Evidence for a heritable predisposition to death due to influenza. J Infect Dis 2008 Jan;197 (published online Dec 11, 2007) [Full text]
Ali T, Scott N, Kallas W, et al. Detection of influenza antigen with rapid antibody-based tests after intranasal influenza vaccination (FluMist). Clin Infect Dis 2004 Mar 1;38(5):760-2 [Abstract]
Alonso WJ, Viboud C, Simonsen L, et al. Seasonality of influenza in Brazil: a traveling wave from the Amazon to the subtropics. Am J Epidemiol 2007 (published online Mar 16) [Abstract]
Ambrose CS, Yi TT, Walker RE, et al. Duration of protection provided by live attenuated influenza vaccine in children. Pediatr Infect Dis J 2008 Aug;27(8):744-8 [Abstract]
Amorij JP, Saluja V, Petersen AH, et al. Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice. Vaccine 2007 Dec 17;25(52):8707-17 [Abstract]
Anikeeva O, Braunack-Mayer A, Rogers W. Requiring influenza vaccination for health care workers. Am J Public Health 2008 (published online Nov 13) [Abstract]
Ansaldi F, Bacilieri S, Durando P, et al. Cross-protection by MF59(TM)-adjuvanted influenza vaccine: neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses. Vaccine 2008 Mar 17;26(12):1525-9 [Abstract]
APIC (Association for Professionals in Infection Control and Epidemiology). Influenza immunization of healthcare personnel. (Position Paper) Released Oct 9, 2008 [Full text]
Apisarnthanarak A, Puthavathana P, Kitphati R, et al. Outbreaks of influenza A among nonvaccinated healthcare workers: implications for resource-limited settings. Infect Control Hosp Epidemiol 2008;29 (published online Jul 14) [Abstract]
Apisarnthanarak A, Puthavathana P, Mundy LM. Risk factors and outcomes of influenza A (H3N2) pneumonia in an area where avian influenza (H5N1) is endemic. Infect Control Hosp Epidemiol 2007 Apr;28(4):479-82 [Abstract]
Arkema JM, Paget WJ, Meijer A, et al. Seasonal influenza beginning in Europe: report from EISS. Eurosurveillance Weekly 2007 Jan 25;12(1):E070125.3 [Full text]
Arkema JMS, Meijer A, Meerhoff TJ, et al. Epidemiological and virological assessment of influenza activity in Europe, during the 2006-2007 winter. Eurosurveillance Aug 21;13(34):pi=18958 [Full text]
Arnoux S, Weinberger C, Gessner BD. Vaccine-preventable influenza disease burden from clinical trials of Vaxigrip--an activated split virion influenza vaccine--supports wider vaccine use. Vaccine 2007 Nov 7;25(45):7720-31 [Abstract]
Ashkenazi S, Vertruyen A, Aristegui J, et al. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Ped Infect Dis J 2006 Oct;15(10):870-9 [Abstract]
Askarian M, Khazaeipour Z, McLaws ML. Influenza vaccination uptake among students and clinical staff of a university in Iran. Int J Infect Dis 2008 (published online Dec 1) [Abstract]
Aspinall R, Del Giudice G, Effros RB, et al. Challenges for vaccination in the elderly. Immun Ageing 2007;4:9 (published online Dec 11) [Abstract]
Atmar RL, Keitel WA, Patel SM, et al. Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations. Clin Infect Dis 2006 Nov 1;43(9):1135?42 [Abstract]
Aucs P, Buchholz U, Haas W, et al. Influenza associated excess mortality in Germany, 1985-2001. Emerg Themes Epidemiol 2005 Jun 21;2:6 [Full text]
Auewarakul P, Kositanont U, Sornsathapornkul P, et al. Antibody responses after dose-sparing intradermal influenza vaccination. Vaccine 2007 Jan 8;25(4):659-63 [Abstract]
Babcock HM, Merz LR, Dubberke ER, et al. Case-control study of clinical features of influenza in hospitalized patients. Infect Control Hosp Epidemiol 2008 Oct;19(10):921-6 [Abstract]
Baldo V, Baldovin T, Floreani A, et al. MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18-60 years of age) with chronic diseases who are at risk of post-influenza complications. Vaccine 2007 May 16;25(20):3955-61 [Abstract]
Balicer RD, Huerta M, Levy Y, et al. Influenza outbreak control in confined settings. Emerg Infect Dis 2005 Apr;11(4):579-83 [Full text]
Bardenheier B, Shefer A, McKibben L, et al. Characteristics of long-term care facility residents associated with receipt of influenza and pneumococcal vaccinations. Infect Control Hosp Epidemiol 2004 Dec;25(11):946-54 [Abstract]
Basta NE, Halloran ME, Matrajt L, et al. Estimating influenza vaccine efficacy from challenge and community-based study data. Am J Epidemiol 2008 (published online Oct 29) [Abstract]
Baumbach JP, Mueller M, Smelser C, et al. Enhancement of influenza surveillance with aggregate rapid influenza test results: New Mexico, 2003-2007. Am J Public Health 2008 (published online Oct 15) [Abstract]
Baz M, Abed Y, McDonald J, et al. Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child. Clin Infect Dis 2006 Dec 15;43(12):1555-61 [Abstract]
Beckett CG, Kosasih H, Ma'roef C, et al. Influenza surveillance in Indonesia: 1999-2003. Clin Infect Dis 2004 Aug 15;39(4):443-9 [Abstract]
Beigel J, Bray M. Current and future antiviral therapy of severe seasonal and avian influenza. Antiviral Res 2008 Apr;78(1):91-102 [Abstract]
Belongia EA, Coleman LA, Donahue JG. Effectiveness of influenza vaccination. (Letter) N Engl J Med 2007 Dec 27;357(26):2728-31 [Full text]
Belsche RB. Translational research on vaccines: influenza as an example. Clin Pharmacol Ther 2007 Dec;82(6):745-9 [Abstract]
Belshe RB, Edwards KM, Vesikari T, et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007 Feb 15;256(7):685-96 [Abstract]
Belshe RB, Gruber WC, Mendelman PM, et al. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr 2000 Feb;136(2):168-75 [Abstract]
Belshe RB, Newman FK, Cannon J, et al. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med 2004 Nov 25;351(22):2286-94 [Full text]
Belshe RB, Newman FK, Wilkins K, et al. Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults. Vaccine 2007 Sep 17;25(37-38):6755-63 [Abstract]
Belshe RB, Nichol KL, Black SB, et al. Safety, efficacy, and effectiveness of live, attenuated, cold-adapted influenza vaccine in an indicated population aged 5-49 years. Clin Infect Dis 2004 Oct 1;39(7):920-7 [Abstract]
Benito-Fernandez J, Vazquez-Ronco M, Morteruel-Aizkuren E, et al. Impact of rapid viral testing for influenza A and B viruses on management of febrile infants without signs of focal infection. Ped Infect Dis J 2006 Dec;25(12):1153-7 [Abstract]
Bergen R, Black S, Shinefield H, et al. Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents. Pediatr Infect Dis J 2004 Feb;23(2):138-44 [Abstract]
Besselaar TG, Naidoo D, Buys A, et al. Widespread oseltamivir resistance in influenza A viruses (H1N1), South Africa. (Letter) Emerg Infect Dis 2008 Nov (published online Sep 25) [Full text]
Beutels P, Scuffham PA, MacIntyre CR. Funding of drugs: do vaccines warrant a different approach? (Personal view) Lancet Infect Dis 2008 Nov;8(11):727-33 [Abstract]
Bhat N, Wright JG, Broder KR, et al. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med 2005 Dec 15;353(24):2559-67 [Abstract]
Bishburg E, Shah M, Mathis AS. Influenza vaccination among medical residents in a teaching hospital. Infect Control Hosp Epidemiol 2008 Jan;29(1):89-91 [Abstract]
Blackburne BP, Hay AJ, Goldstein RA. Changing selective pressure during antigenic changes in human influenza H3. PLoS Pathog 2008 May 2;4(5):e1000058 [Full text]
Blank PR, Freiburghaus AU, Schwenkglenks M, et al. Trends in influenza vaccination coverage rates in the United Kingdom over six seasons from 2001-2 to 2006-7. Eurosurveill 2008 Oct 23;13(43):3 [Full text]
Blank PR, Schwenkglenks M, Szucs TD. Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons. BMC Public Health 2008 Aug 1;8:272 [Abstract - with link to full text]
Bodor M, Montalvo E. Vaccination-related shoulder dysfunction. Vaccine 2007 Jan 8;25(4):585-7 [Abstract]
Booy R, El Bashir H, Rashid H, et al. Influenza and meningococcal disease: lessons for travellers and government from 2 epidemic diseases. Trav Med Infect Dis 2008 (published online Nov 14) [Abstract]
Borlaug G, Newman A, Pfister J, et al. Factors that influenced rates of influenza vaccination among employees of Wisconsin acute care hospitals and nursing homes during the 2005-2006 influenza season. Infect Control Hosp Epidemiol 2007 Dec;28(12):1398-1400 [Abstract]
Bose ME, Littrell JC, Patzer AD, et al. The influenza primer design resource: a new tool for translating influenza sequence data into effective diagnostics. Influenza Other Resp Viruses 2008 Jan;2(1):23-31 [Abstract]
Bouvier NM, Lowen AC, Palese P. Oseltamivir-resistant influenza A viruses transmit efficiently among guinea pigs by direct contact but not by aerosol. J Virol 2008 Oct;82(20):10052-8 [Abstract]
Bragstad K, Nielsen LP, Fomsgaard A. The evolution of human influenza A viruses from 1999 to 2006 - a complete genome study. Virol J 2008 Mar 7;5(1):40 [Abstract]
Brankston G, Gitterman L, Hirji A, et al. Transmission of influenza A in human beings. Lancet Infect Dis 2007, published online Feb 19 [Abstract]
Brett AS, Zuger A. The run on Tamiflu: should physicians prescribe on demand? (Perspective) N Engl J Med 2005 Dec 22;353(24):2636-7 [Full text]
Brewer NT, Hallman WK. Subjective and objective risk as predictors of influenza vaccination during the vaccine shortage of 2004-2005. Clin Infect Dis 2006 Dec 1;43(11):1379-86 [Abstract]
Bright RA, Carter DM, Daniluk S, et al. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine 2007 May 10;25(19):3781-8 [Abstract]
Bright RA, Medina M, Xu X, et al. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 2005 Oct 1;366(9492):1175-81 [Abstract]
Bright RA, Shay DK, Shu B, et al. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 2006 (published online Feb 2) [Abstract]
Bright RA, Shay DK, Shu B, et al. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 2006 Feb 22;295(8):891-4 [Abstract]
Brooks WA, Terebuh P, Bridges C, et al. Influenza A and B infection in children in urban slum, Bangladesh. (Letter) Emerg Infect Dis 2007 Oct;13(10):1507-8 [Full text]
Brown AS, Begg MD, Gravenstein S, et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 2004;61(8):774-80 [Abstract]
Brownstein JS, Kleinman KP, Mandl KD. Identifying pediatric age groups for influenza vaccination using a real-time regional surveillance system. Am J Epidemiol 2005 Oct 1;162(7):686-93 [Abstract]
Brownstein JS, Wolfe CJ, Mandl KD. Empirical evidence for the effect of airline travel on inter-regional influenza spread in the United States. PLoS Med 2006 Oct;3(10) [Full text]
Bryant KA, Stover B, Cain L, et al. Improving influenza immunization rates among healthcare workers caring for high-risk pediatric patients. Infect Control Hosp Epidemiol 2004 Dec;25(11):912-7 [Abstract]
Bucher SJ, Brickner PW, Vincent RL. Influenzalike illness among homeless persons. (Letter) Emerg Infect Dis 2006 Jul;12(7) [Full text]
Bui HH, Peters B, Assarsson E, et al. Ab and T cell epitopes of influenza A virus, knowledge and opportunities. Proc Natl Acad Sci 2007 Jan 2;104(1):246-51 [Abstract]
Bulimo WD, Garner JL, Schnabel DC, et al. Genetic analysis of H3N2 influenza A viruses isolated in 2006-2007 in Nairobi, Kenya. Influenza Other Resp Viruses 2008 (published online Jun 2) [Abstract]
Burbacher TM, Shen DD, Liberato N, et al. Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal. Environ Health Perspect 2005 (published online Apr 21) [Full text]
Cabello J, Das K, Trick WE, et al. House staff attitudes about influenza vaccination after participation in a clinical trial to improve vaccination of hospital patients. Infect Control Hosp Epidemiol 2008 Feb (published online Dec 28) [Abstract]
Carpenter LR, Lott J, Lawson BM, et al. Mass distribution of free, intranasally administered influenza vaccine in a public school system. Pediatrics 2007 (published online Jun 25) [Abstract]
Carrat F, Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine 2007 Sep 28;25(39-40):6852-62 [Abstract]
Carrat F, Vergu E, Ferguson NM, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008 Apr 1;167(7):775-85 [Full text]
CDC. 2005-06 U.S. influenza season summary. Jul 21, 2006 [Full text]
CDC. Assessment of the effectiveness of the 2003-04 influenza vaccine among children and adults: Colorado, 2003. MMWR Aug 13;53(31):707-10 [Full text]
CDC. Brief report: Influenza vaccination coverage among children aged 6-23 months--six immunization information system sentinel sites, United States, 2005-06 influenza season. MMWR 2006 Dec 15;55(49):1329-30 [Full text]
CDC. CDC guidelines for large-scale influenza vaccination clinic planning. May 23, 2007 [Full text]
CDC. CDC guidelines for large-scale influenza vaccination clinic planning: guidelines for the tiered use of inactivated influenza vaccine. May 23, 2007 [Full text]
CDC. CDC recommends against the use of amantadine and rimantadine for the treatment or prophylaxis of influenza in the United States during the 2005-2006 influenza season. CDC Health Alert. Jan 14, 2006 [Full text]
CDC. Childhood influenza vaccination coverage--United States, 2004-05 influenza season. MMWR 2006 Oct 6;55(39):1062-5 [Full text]
CDC. Childhood influenza vaccination coverage: United States, 2003-04 influenza season MMWR 2006 Feb 3;55(04):100-3 [Full text]
CDC. Childhood influenza-vaccination coverage: United States, 2002-03 influenza season. MMWR 2004 Sep 24;53(37):863-6 [Full text]
CDC. Composition of the 2005-06 influenza vaccine. Published Apr 18, 2005; updated May 13, 2005 [Full text]
CDC. Destruction of influenza A (H2N2) proficiency testing samples; interim guidance for biosafety level 3-enhanced biocontainment for work with human influenza A (H2N2) viruses. May 3, 2005 [Full text]
CDC. Estimated influenza vaccination coverage among adults and children--United States, September 1, 2004-January 31, 2005. MMWR 2005 April 1;54(12):304-7 [Full text]
CDC. Estimates of influenza vaccination target population sizes in 2006 and recent vaccine uptake levels. Jul 17, 2006 [Full text]
CDC. Experiences with influenza-like illness and attitudes regarding influenza prevention: United States, 2003-04 influenza season. MMWR 2004 Dec 17;53(49):1156-8 [Full text]
CDC. Flu vaccine effectiveness: questions and answers for health professionals. Published online Jan 11, 2007 [Full text]
CDC. High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents: United States 2005-06 influenza season. MMWR 2006 Jan 17;55(Dispatch):1-2 [Full text]
CDC. Increased antiviral medication sales before the 2005-06 influenza season: New York City. MMWR 2006 Mar 17;55(10):277-9 [Full text]
CDC. Infection control measures for preventing and controlling influenza transmission in long-term care facilities. Revised Dec 23, 2005 [Full text]
CDC. Influenza activity--United States and worldwide, 2007-08 season. MMWR 2008 Jun 27;57(26):692-97 [Full text]
CDC. Influenza activity--United States and worldwide, May 18-September 19, 2008. MMWR 2008 Sep 26;57(38):1046-9 [Full text]
CDC. Influenza activity: United States and worldwide, 2005-06 season, and composition of the 2006-07 influenza vaccine. MMWR 2006 Jun 16;55(23)648-53 [Full text]
CDC. Influenza activity: United States and worldwide, May 21 - September 9, 2006. MMWR 2006 Sep 22;55(37):1021-3 [Full text]
CDC. Influenza activity: United States and worldwide, May 22 - Sep 3, 2005, and 2005-06 season vaccination recommendations. MMWR 2005 Sep 16;54(36):899-902 [Full text]
CDC. Influenza activity: United States, October 1 - December 9, 2006. MMWR 2006 Dec 22;55(50):1359-62 [Full text]
CDC. Influenza activity: United States, September 30-December 1, 2007. MMWR 2007 Dec 14;56(49):1287-91 [Full text]
CDC. Influenza and pneumococcal vaccination coverage among persons aged >/=65 Years--United States, 2004-2005. MMWR 2006 Oct 6;55(39):1065-8 [Full text]
CDC. Influenza and pneumonococcal vaccination coverage among persons aged >/=65 years with diabetes or asthma: United States, 2003. MMWR 2004 Nov 5;53(43):1007-12 [Full text]
CDC. Influenza antiviral medications: 2005-06 interim chemoprophylaxis and treatment guidelines. Oct 21, 2005 [Web page]
CDC. Influenza vaccination and self-reported reasons for not receiving influenza vaccination among Medicare beneficiaries aged >/=65 years: United States, 1991-2002. MMWR 2004 Nov 5;53(43):1012-5 [Full text]
CDC. Influenza vaccination coverage among children aged 6-23 months--United States, 2005-06 influenza season. MMWR 2007 Sep 21;56(37):959-63 [Full text]
CDC. Influenza vaccination coverage among children aged 6-23 Months--United States, 2006-07 influenza season. MMWR 2008 Sep 26;57(38):1039-43 [Full text]
CDC. Influenza vaccination coverage among children aged 6-59 Months--eight immunization information system sentinel sites, United States, 2007-08 influenza season. MMWR 2008 Sep 26;57(38):1043-6 [Full text]
CDC. Influenza vaccination coverage among children aged 6-59 months--six immunization information system sentinel sites, United States, 2006-07 influenza season. MMWR 2007 Sep 21;56(37):963-5 [Full text]
CDC. Influenza vaccination coverage among children with asthma--United States, 2004-05 influenza season. MMWR 2007 Mar 9;56(9):193-6 [Full text]
CDC. Influenza vaccination coverage among persons aged 50-64 years enrolled in commercial managed health-care plans. MMWR 2005 Sep 23;54(37):921-3 [Full text]
CDC. Influenza vaccination coverage among persons with asthma--United States, 2005-06 influenza season. MMWR 2008 Jun 20;57(24):653-7 [Full text]
CDC. Influenza vaccination in pregnancy: practices among obstetrician-gynecologists: United States, 2003-04 influenza season. MMWR 2005 Oct 21;54(41):1050-2 [Full text]
CDC. Influenza vaccination levels among persons aged >/=65 years and among persons aged 18-64 years with high-risk conditions: United States, 2003. MMWR 2005 Oct 21;54(41):1045-9 [Full text]
CDC. Influenza vaccine prebooking and distribution strategies for the 2005-06 influenza season. MMWR 2005 April 1;54(12):307-8 [Full text]
CDC. Influenza vaccine supply and recommendations for prioritization during the 2005-06 influenza season. MMWR 2005 Sep 2;54(34):850 [Full text]
CDC. Influenza-associated pediatric mortality and Staphylococcus aureus co-infection. (CDC Health Advisory) Jan 30, 2008 [Full text]
CDC. Influenza-associated pediatric mortality and the increase of Staphylococcus aureus co-infection. (CDC Health Advisory) May 9, 2007 [Full text]
CDC. Influenza-testing and antiviral-agent prescribing practices--Connecticut, Minnesota, New Mexico, and New York, 2006-07 influenza season. MMWR 2008 Jan 25;57(3):61-5 [Full text]
CDC. Interim CDC-NIH recommendation for raising the biosafety level for laboratory work involving noncontemporary human influenza (H2N2) viruses. Excerpted from draft: Biosafety in microbiological and biomedical laboratories. Ed 5. May 3, 2005 [Full text]
CDC. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season. MMWR 2008 Apr 18;57(15):393-8 [Full text]
CDC. Interventions to increase influenza vaccination of health-care workers. MMWR 2005 Mar 4;54(8) [Full text]
CDC. Notice to readers: Expansion of use of live attenuated influenza vaccine (FluMist) to children aged 2-4 years and other FluMist changes for the 2007-08 influenza season. MMWR Nov 23;56(46):1217-9 [Full text]
CDC. Notice to readers: National Influenza Vaccination Week--November 26-December 2, 2007. MMWR Nov 23;56(46):1216-7 [Full text]
CDC. Preventing the spread of influenza (the flu) in child care settings: guidance for administrators, care providers, and other staff. Posted Oct 2, 2007 [Full text]
CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR 2007 Jun 29;56(Early Release):1-54 [Full text]
CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR 2008 Jul 17;57(Early Release):1-60 [Full text]
CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2006 Jun 28;55(Early release):1-41 [Full text]
CDC. Q&A: Seasonal influenza vaccine supply for the U.S. 2007-08 influenza season. Oct 12, 2007 [Full text]
CDC. Q&A: Thimerosal in seasonal influenza vaccine. Oct 12, 2007 [Full text]
CDC. Questions & answers: vaccine effectiveness (How well does the influenza or 'flu' vaccine work?). Published online Jan 11, 2007 [Full text]
CDC. Rapid assessment of influenza vaccination coverage among HMO members: northern California influenza seasons, 2001-02 through 2004-05. MMWR 2005 Jul 15;54(27):676-8 [Full text]
CDC. Severe morbidity and mortality associated with influenza in children and young adults: Michigan, 2003. MMWR 2003:52(35):837-40 [Full text]
CDC. State-specific influenza vaccination coverage among adults aged >/= 18 years--United States, 2003-04 and 2005-06 influenza seasons. MMWR 2007 Sep 21;56(37):953-9 [Full text]
CDC. State-specific influenza vaccination coverage among adults--United States, 2006-07 influenza season. MMWR 2008 Sep 26;57(38):1033-9 [Full text]
CDC. Surveillance for laboratory-confirmed, influenza-associated hospitalizations: Colorado, 2004-05 influenza season. MMWR 2005 Jun 3;54(21):535-7 [Full text]
CDC. Tiered use of inactivated influenza vaccine in the event of a vaccine shortage. MMWR 2005 Aug 5;54(30):749-50 [Full text]
CDC. Update on the influenza vaccine supply and distribution. Nov 10, 2005 [Full text]
CDC. Update: influenza activity--United States and worldwide, 2006-07 season, and composition of the 2007-08 influenza vaccine. MMWR 2007 Aug 10;56(31):789-94 [Full text]
CDC. Update: influenza activity--United States and worldwide, May 20-September 15, 2007. MMWR 2007 Sep 28;56(3):1001-4 [Full text]
CDC. Update: influenza activity--United States, October 1, 2006-February 3, 2007. MMWR 2007 Feb 16;56(6):118-21 [Full text]
CDC. Update: influenza activity--United States, September 30, 2007-April 5, 2008, and composition of the 2008-09 influenza vaccine. MMWR 2008 Apr 18;57(15):404-9 [Full text]
CDC. Update: influenza activity--United States, September 30, 2007-February 9, 2008. MMWR 2009 Feb 15;57(early release):1-5 [Full text]
CDC. Using live, attenuated influenza vaccine for prevention and control of influenza: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2003 Sep 26:52(RR13):1 [Full text]
CDC. Vaccination coverage among callers to a state influenza hotline: Connecticut, 2004-2005 influenza season. MMWR 2005 Mar 4;54(8) [Full text]
CDC/NIH. Statement on Simonsen et al article "Impact of influenza vaccination on seasonal mortality in the US elderly population" below. Feb 2005 [Full text]
Chen G-W, Yang C-C, Tsao K-C, et al. Influenza A virus PB1-F2 gene in recent Taiwanese isolates. Emerg Infect Dis 2004 Apr;10 (4):630-8 [Full text]
Chen GW, Shih SR, Hsiao MR, et al. Multiple genotypes of influenza B viruses cocirculated in Taiwan in 2004 and 2005. J Clin Microbiol 2007 May;45(5):1515-22 [Abstract]
Chen J, Zhang F, Fang F, et al. Vaccination with hemagglutinin or neuraminidase DNA protects BALB/c mice against influenza virus infection in presence of maternal antibody. BMC Infect Dis 2007;7:118 (published online Oct 16) [Abstract]
Chi RC, Neuzil KM, Lipsky BA, et al. Where high-risk adults receive influenza vaccine during a shortage. Arch Intern Med 2007 Nov 26;167(21):2366-8 [Extract]
Chiu SS, Peiris JSM, Chan KH, et al. Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children. Pediatrics 2007 Jun;119(6):1076-82 [Abstract]
Cho BH, Kolasa MS, Messonnier ML. Influenza vaccination coverage rate among high-risk children during the 2002-2003 influenza season. Am J Infect Control 2008 Oct;36(8):582-7 [Abstract]
Chou CH, Liou WP, Hu KI, et al. Bell's palsy associated with influenza vaccination: two case reports. Vaccine 2007 Apr 12;25(15):2839-41 [Abstract]
Chow A, Ma S, Ling AE, et al. Influenza-associated deaths in tropical Singapore. Emerg Infect Dis 2006 Jan;12(1) [Full text]
Christenson B, Pauksen K, Sylvan SP. Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity. Virology J 2008 Apr 28;5:52 [Abstract]
Christini AB, Shutt KA, Byers KE. Influenza vaccination rates and motivators among healthcare worker groups. Infect Control Hosp Epidemiol 2007 Feb;28(2):171-7 [Abstract]
Chun S, Li C, Domselaar GV, et al. Universal antibodies and their applications to the quantitative determination of virtually all subtypes of the influenza A viral hemagglutinins. Vaccine 2008 Nov 11;26(48):6068-76 [Abstract]
Coady MH, Galea S, Blaney S, et al. Project VIVA: a multilevel community-based intervention to increase influenza vaccination rates among hard-to-reach populations in New York City. Am J Public Health 2008 Jul;98(7):1314-21 [Abstract]
Coffin SE, Zaoutis TE, Wheeler Rosenquist AB, et al. Incidence, complications, and risk factors for prolonged stay in children hospitalized with community-acquired influenza. Pediatrics 2007 Apr(4);119:740-8 [Abstract]
Cohen NJ, Morita JY, Plate DK, et al. Control of an outbreak due to an adamantane-resistant strain of influenza A (H3N2) in a chronic care facility. Infection 2008 (published online Sep 14) [Abstract]
Cohen S, Alper CM, Doyle WJ, et al. Positive emotional style predicts resistance to illness after experimental exposure to rhinovirus or influenza A virus. Psychosom Med 2006 (published online Nov 13) [Abstract]
Coleman MS, Fontanesi J, Meltzer MK, et al. Estimating medical practice expenses from administering adult influenza vaccinations. Vaccine 2005 Jan 4;23(7):915-23 [Abstract]
Colina R, Costa-Mattioli M, Dowling RJO, et al. Translational control of the innate immune response through IRF-7. Nature 2008 Mar 20;452(7185):323-8 (published online Feb 13) [Abstract]
Conti G, Magliani W, Conti S, et al. Therapeutic activity of an anti-idiotypic antibody-derived killer peptide against influenza A virus experimental infection. Antimicrob Agents Chemother 2008 Dec;52(12):4331-7 [Abstract]
Cooper DL, Smith GE, Regan M, et al. Tracking the spatial diffusion of influenza and norovirus using telehealth data: a spatio-temporal analysis of syndromic data. BMC Med 2008 Jun 26;6:16 [Abstract]
Couch RB, Winokur P, Brady R, et al. Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects. Vaccine 2007 Nov 1;25(44):7656-63 [Abstract]
Cowling BJ, Lau EHY, Lam CLH, et al. Effects of school closures, 2008 winter influenza season, Hong Kong. Emerg Infect Dis 2008 Oct;14(10) (published online Sep 11) [Full text]
Cox NJ, Bridges CB. Inactivated and live attenuated influenza vaccines in young children--how do they compare? (Editorial) N Engl J Med 2007 Feb 15;256(7):729-31 [Abstract]
Crawford LM. FDA's ongoing efforts to ensure the safety, effectiveness, and availability of influenza and other vaccines. Testimony before Senate Special Committee on Aging. Nov 16, 2004 [Full text]
Crepey P, Barthelemy M. Detecting robust patterns in the spread of epidemics: a case study of influenza in the United States and France. Am J Epidemiol 2007 (published online Oct 15) [Abstract]
D'Heilly SJ, Nichol K. Work-site-based influenza vaccination in healthcare and non-healthcare settings. Infect Control Hosp Epidemiol 2004 Dec;25(11):941-5 [Abstract]
Das K, Ma LC, Xiao R, et al. Structural basis for suppression of a host antiviral response by influenza A virus. Proc Natl Acad Sci 2008 (published online Aug 25) [Abstract, with link to free full text]
Daum LT, Shaw M, Klimov AI, et al. Influenza A (H3N2) outbreak, Nepal. Emerg Infect Dis 2005 Aug;11(8) [Full text]
Davila JC, Payne DC, Zhang Y, et al. Quality assessment of nonanthrax vaccination data in the Defense Medical Surveillance System, 1998-2004. Vaccine 2008 Mar 17;26(12):1577-84 [Abstract]
Dawson ED, Moore CL, Smagala JA, et al. MChip: a tool for influenza surveillance. Anal Chem Nov 15;78(22):7610-5 [Abstract]
de Bruijn I, Meyer I, Gerez L, et al. Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly. Vaccine 2007 Dec 21;26(21):119-27 [Abstract]
Denis J, Acosta-Ramirez E, Zhao Y, et al. Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV). Vaccine 2008 Jun 25;26(27-28):3395-403 [Abstract]
Desbiens NA. A 5-year experience with influenza prevention and containment in a program of all-inclusive care for elderly adults. Am J Infect Control 2005 May;33(4):238-42 [Abstract]
DesRoches CM, Blendon RJ, Benson JM. Americans' responses to the 2004 influenza vaccine shortage. Health Affairs 2005 May 24(3):822-31 [Abstract]
Deyde VM, Xu X, Bright RA, et al. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J Infect Dis 2007 Jul 15;196(2):249-57 [Full text]
Dimmock NJ, Rainsford EW, Scott PD, et al. Influenza virus protecting RNA: an effective prophylactic and therapeutic antiviral. J Virol 2008 Sep;82(17):8570-78 [Abstract]
Dodds L, McNeill SA, Fell DB, et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ 2007 Feb 13;176(4):463-8 [Abstract]
Doherty PC, Kelso A. Toward a broadly protective influenza vaccine. (Commentary) J Clin Invest 2008 (published online Sep 18) [Full text]
Dolin R. Influenza: interpandemic as well as pandemic disease. (Perspective) N Engl J Med 2005 Dec 15;353(24):2535-7 [Extract]
Donato AA, Motz LM, Wilson G, et al. Efficacy of multiple influenza vaccine delivery systems in a single facility. Infect Control Hosp Epidemiol 2007 Feb;28(2):219-21 [Abstract]
Doratotaj S, Macknin ML, Worley S. A novel approach to improve influenza vaccination rates among health care professionals: a prospective randomized controlled trial. Am J Infect Control 2008 May;36(4):301-303 [Abstract]
Doshi P. Trends in recorded influenza mortality: United States, 1900-2004. Am J Public Health 2008 (published online Apr 1) [Abstract]
Durando P, Fenoglio D, Boschini A, et al. Safety and immunogenicity of two influenza subunit vaccines, with or without MF59 adjuvant, administered to HIV-1 seropositive and seronegative adults. Clin Vaccine Immunol 2007 (published online Nov 14) [Abstract]
Dushoff J, Plotkin JB, Viboud C, et al. Vaccinating to protect a vulnerable subpopulation. PLoS Med 2007 May;4(5):e174 [Full text]
Duwe S, Schweiger B. A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1. J Virol Method 2008 (published online Aug 22) [Abstract]
Dwyer DE, Smith DW, Catton MG, et al. Laboratory diagnosis of human seasonal and pandemic influenza virus infection. Med J Aust 2006 Nov 20;185(10 suppl):S48-53 [Full text]
Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect Dis 2005 Nov;5(11):718-25 [Abstract]
ECDC (European Centre for Disease Prevention and Control). Oseltamivir resistance in seasonal influenza viruses in Europe. Feb 13, 2008 [Full text]
ECDC (European Center for Disease Prevention and Control). Resistance to oseltamivir (Tamiflu) found in some European influenza virus samples. ECDC News 2008 Feb 7 [Full text]
ECDC Influenza Project Team. Oseltamivir resistance in human seasonal influenza viruses (A/H1N1) in EU and EFTA countries: an update. Eurosurveill 2008 Feb 7;13(6) [Full text]
Eichelberger M, Golding H, Hess M, et al. FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007. Vaccine 2008 Aug 12;26(34):4299-303 [Abstract]
Eisenberg KW, Szilagyi PG, Fairbrother G, et al. Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons. Pediatrics 2008 Nov;122(5):911-9 [Abstract]
El Sahly HM, Keitel WA. Clinical data on Fluarix: an inactivated split seasonal influenza vaccine. Expert Rev Vaccines 2008 Aug;7(6):713-9 [Abstract]
Eliasson DG, Bakkouri KE, Schon K, et al. CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine. Vaccine 2008 Feb 26;26(9);1243-52 [Abstract]
Esposito S, Gasparini C, Martelli A, et al. Safe administration of an inactivated virosomal adjuvanted influenza vaccine in asthmatic children with egg allergy. Vaccine 2008 Aug 26;26(36):4664-8 [Abstract]
Esposito S, Tremolati E, Bellasio M, et al. Attitudes and knowledge regarding influenza vaccination among hospital health workers caring for women and children. Vaccine 2007 Jul 20;25(29):5283-9 [Abstract]
Eurosurveillance Editorial Team. Influenza activity in the Southern Hemisphere: a preliminary look at the winter 2007 season. Eurosurveillance Weekly 2007 Aug 23;12(8):E070823.4 [Full text]
Eurosurveillance Editorial team. New WHO influenza vaccine recommendations for 2007-2008 season, northern hemisphere. Eurosurveillance Weekly 2007 Apr 5;12(4):E070405.4 [Full text]
Fabian P, McDevitt JJ, DeHaan WH, et al. Influenza virus in human exhaled breath: an observational study. PLoS ONE 2008 Jul 16;3(7):e2691 [Full text]
Falsey AR, Murata Y, Walsh EE. Impact of rapid diagnosis on management of adults hospitalized with influenza. Arch Intern Med 2007;167(4) (published online Jan 22) [Abstract]
Fauci AS. Seasonal and pandemic influenza preparedness: science and countermeasures. J Infect Dis 2006 Nov 1;194(suppl 2):S73-6 [Abstract]
FDA. FDA clears first test designed to detect and identify 12 respiratory viruses from single sample. Jan 3, 2008, news release [Full text]
FDA. Guidance for industry: clinical data needed to support the licensure of seasonal inactivated influenza vaccines. May 31, 2007 [Full text]
Fedson DS. Vaccination for pandemic influenza and severe acute respiratory syndrome: common issues and concerns. (Editorial Commentary) Clin Infect Dis 2003 Jun 15;36(12):1562-3 [Full text]
Ferko B, Kittel C, Romanova J, et al. Live attenuated influenza virus expressing human interleukin-2 reveals increased immunogenic potential in young and aged hosts. J Virol 2006 Dec;80(23):11621-7 [Abstract]
Finelli L, Fiore A, Dhara R, et al. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics 2008 Oct;122(4):805-11 [Abstract]
Finkelman BS, Viboud C, Koelle K, et al. Global patterns in seasonal activity of influenza A/H3N2, A/H1N1, and B from 1997 to 2005: viral coexistence and latitudinal gradients. PLoS ONE Dec 12;2(12):e1296 [Full text]
Fleming DM, Crovari P, Wahn U, et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Ped Infect Dis J 2006 Oct;15(10):860-9 [Abstract]
France EK, Smith-Ray R, McClure D, et al. Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits. Arch Pediatr Adolesc Med 2006 Dec 160(12):1277-83 [Abstract]
Fraser C, Riley S, Anderson RM, et al. Factors that make an infectious disease outbreak controllable. Proc Natl Acad Sci 2004 Apr 20;101(16):6146-51 [Abstract]
Frech SA, Kenney RT, Spyr CA, et al. Improved immune responses to influenza vaccination in the elderly using an immunostimulant patch. Vaccine 2005 Jan 4;23(7):946-50 [Abstract]
Frisbie B, Tang YW, Griffin M, et al. Surveillance of childhood influenza virus infection: what is the best diagnostic method to use for archival samples? J Clin Microbiol 2004 Mar;42(3):1181-4 [Abstract]
Fujisawa H. Neutrophils play an essential role in cooperation with antibody in both protection against and recovery from pulmonary infection with influenza virus in mice. J Virol 2008 Mar;82(6):2772-83 [Abstract]
Fukuda K, Kieny MP. Different approaches to influenza vaccination. N Engl J Med 2006 Dec 14;355(24):2586-7 [Full text]
Gaglia MA Jr, Cook RL, Kraemer KL, et al. Patient knowledge and attitudes about antiviral medication and vaccination for influenza in an internal medicine clinic. Clin Infect Dis 2007 Nov 1;45(9):1182-8 [Abstract]
Gallagher KM, Juhasz M, Harris NS, et al. Predictors of influenza vaccination in HIV-infected patients in the United States, 1990-2002. J Infect Dis 2007 Aug 1;196(3):339-46 [Abstract]
Galvani AP, Reluga TC, Chapman GB. Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum. Proc Natl Acad Sci 2007 (published online Mar 16) [Abstract]
GAO (Government Accountability Office). Federal challenges in responding to influenza outbreaks. Testimony of Janet Heinrich before Special Committee on Aging, US Senate. GAO-04-1100T. Sep 28, 2004 [Full text]
GAO (Government Accountability Office). Flu vaccine: recent supply shortages underscore ongoing challenges. Congressional testimony by Janet Heinrich. GAO-05-177T. Nov 18, 2004 [Full text]
GAO (US Government Accountability Office). Influenza vaccine: issues related to production, distribution, and public health messages. GAO-08-27. Released Nov 16, 2007 (but dated Oct 31) [Full text]
Gatrad AR, Shafi S, Memish ZA, et al. Hajj and the risk of influenza (Editorial). BMJ 2006 Dec 9;333(7580):1182-3 [Extract]
Gaydos JC, Top FH Jr, Hodder RA, et al. Swine influenza A outbreak, Fort Dix, New Jersey, 1976. Emerg Infect Dis 2006 Jan;12(1) [Full text]
Gazmararian JA, Coleman M, Prill M, et al. Influenza vaccination of health care workers: policies and practices of hospitals in a community setting. Am J Infect Control 2007 Sep;25(7):441-7 [Abstract]
Ge Q, Filip L, Bai A, et al. Inhibition of influenza virus production in virus-infected mice by RNA interference. Proc Natl Acad Sci 2004 Jun 8;101(23):8676-81 [Abstract]
Gerberding J. Letter to healthcare providers on National Influenza Vaccination Week. Nov 21, 2006 [Full text]
Gerberding JL. Influenza and influenza vaccine safety and supply. Statement before House Committee on Appropriations Subcommittee on Labor, Health and Human Services & Education. Oct 5, 2004 [Full text]
Gerhard W, Mozdzanowska K, Zharikova D. Prospects for universal influenza virus vaccine. Emerg Infect Dis 2006 Apr; 12(4) [Full text]
Ghedin E, Sengamalay NA, Shumway M, et al. Large-scale sequencing of human influenza reveals the dyn | 
